Physician profile
James H Beebe
NPI 1407047723
$66,423.76
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,672 · 2020: $6,634 · 2021: $106 · 2022: $16K · 2023: $12K · 2024: $18K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Travel and Lodging: $2,253 · Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,740.00 |
| Travel and Lodging | $2,252.70 |
| Food and Beverage | $2,193.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $64,839.42 | 2019-2025 | Puraply Wound Matrix, Affinity, Puraply |
| Kerecis Limited | $524.45 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $335.72 | 2019-2025 | Collagenase Santyl, Oasis |
| Integra Lifesciences Corporation | $290.40 | 2020-2023 | Tcc-Ez |
| Mimedx Group, INC. | $270.80 | 2024-2025 | |
| Sanofi Pasteur INC. | $55.88 | 2019 | |
| Solventum Corporation | $41.49 | 2025 | Activ.A.C., 3m Cavilon, V.A.C.Instill |
| Paratek Pharmaceuticals, INC. | $18.46 | 2023 | Nuzyra |
| Novo Nordisk INC | $17.98 | 2020 | |
| Tactile Systems Technology INC | $17.05 | 2024 | Entre Plus, Flexitouch Plus |
| Convatec INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Beebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.